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ABSTRACT 
Objective: Hospital-based ADR (Adverse drug reaction) monitoring and reporting programmes are useful for identifying and minimizing 
preventable ADRs and may enhance the ability of prescribers to manage ADRs more effectively. The objective of this study was to evaluate and 
analyze the spontaneously reported adverse drug events from various departments of Shree Krishna Hospital, Karamsad. 
Methods: This was a retrospective study and data was analyzed for adverse drug events reported during the period of April 2018 to March 2019 
from various departments of Shree Krishna Hospital, Karamsad. Analysis was done on the basis of the demographic profile of patients, health care 
professionals who have reported and drugs causing ADRs, with their causality assessment using WHO probability scale. 
Results: Out of 36 patients, 20 (55.55%) were males and 16 (44.44%) were females. Antibiotics were the most common culprit group of drugs for 
reported ADRs in 21 patients. The number of ADRS related to the skin was 21 (58.33%) followed by GIT 11 (30.55%), cardiovascular 2(5.55%) and 
neuronal 2(5.55%). According to WHO causality assessment scale 01 (2.77%) of the suspected ADR was certain, 27(75%) were probable and 8 
(22.22%) were possible. 
Conclusion: Our study concluded that the most commonly reported ADRs were dermatological reactions like itching and rashes. Antimicrobials 
were the most common drug group involved in causing ADRs. Even though there were continuous efforts for adverse drug event reporting 
awareness, still there is need to sensitize health care professionals to improve reporting. 
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INTRODUCTION 
Adverse drug reactions (ADRs) are one of the leading causes of 
mortality and morbidity in health care and entail a significant 
burden on healthcare facilities. ADRs can also lead to an increase in 
the length of hospital stay and sometimes requiring additional 
investigations and drug therapies for the treatment of symptoms 
and diseases caused to the patient [1, 2]. Pharmacovigilance 
programme of India was introduced in 2010 with the vision to 
improve patient safety and welfare of Indian population by 
monitoring the safety of medicines and thereby reducing the risk 
associated with their use [3]. Hospital-based ADR monitoring and 
reporting programmes are useful for identifying and minimizing 
preventable ADRs and may enhance the ability of prescribers to 
manage ADRs more effectively [4]. The study site is Shree Krishna 
Hospital, Karamsad, which is attached to MCI recognized medical 
college and is one of the peripheral ADR monitoring centers of India. 
The objective of this study was to evaluate and analyze the 
spontaneously reported adverse drug events from the various 
departments of Shree Krishna Hospital, Karamsad. 
MATERIALS AND METHODS 
This was a retrospective study which was approved by the 
institutional ethics committee (IEC: Cr.33/196/19). The data were 
analyzed for adverse drug events reported during the period of April 
2018 to March 2019 from various departments of Shree Krishna 
Hospital, Karamsad. Analysis was done on the basis of demographic 
profile of patients, drugs causing ADRs with their causality 
assessment using WHO probability scale. ADRs were also analyzed 
on the basis of health care professionals who have reported. 
Descriptive statistics were used for the data analysis. 
RESULTS 
A total of 36 ADRs were reported in this study. Out of 36 patients, 20 
(55.55%) were males and 16 (44.44%) were females. All the reported 
ADRs were confirmed by treating physicians. Seventeen ADRs were 
reported from age group below 18 y, followed by fifteen ADRs from 
age group 18-60 y and four ADRs were reported from age group above 
60 y. Age and gender-wise distribution of ADRs are shown in table 1. 
Total 31(86.11%) ADRs were reported from inpatient departments 
and 5 (13.88%) were from outpatient departments. Most of the ADRs 
were reported from pediatrics 15 (41.66%) followed by medicine 06 
(16.66%), skin 05 (13.88%) and surgery 04 (11.11%) departments, as 
shown in fig. 1. Majority of ADRs 30 (83.33%) were reported by 
prescribers themselves. Six (16.66%) ADRs were reported by other 
health care professionals as shown in fig. 2. 
Suspected drugs with their formulations and reported ADRs are shown 
in table 2. Most of the ADRs were reported from injectable medications 
followed by medications given by oral route. Antibiotics were the most 
common culprit group of drugs for reported ADRs in 21 patients as 
shown in table 2. Among antibiotics, a fixed-dose combination of 
antitubercular drugs and single-dose formulation of vancomycin was 
reported in six patients each. The number of ADRS related to the skin 
were 21 (58.33%) followed by GIT 11 (30.55%), cardiovascular 
2(5.55%) and neuronal 2(5.55%) as shown in fig. 3. According to WHO 
causality assessment scale 01(2.77%) of the suspected ADR was certain, 
27(75%) were probable and 8 (22.22%) were possible as shown in fig. 4. 
 
Table 1: Demographic details 
Age (Y) Male (n) Female (n) Total (n) 
<18 10 07 17 
18-60 08 07 15 
>60 02 02 4 
 20 16 36 
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Fig. 1: Department wise reporting of ADR 
 
 
Fig. 2: Percentage of ADRs reported by different health care professionals 
 
Table 2: Causative drugs and adverse drug reactions 




Adverse drug reactions (frequency) 
Anticoagulants  
Injection Heparin 01 00 Haematoma and blackening of skin over injection site (01) 
Antispasmodic  
Injection Dicyclomine 01 00 Intussusception (01) 
Antiemetics  
Injection Metoclopramide 01 00 Extrapyramidal side effects (01) 
Antibiotics  
Injection Vancomycin 06 00 Rashes (05), injection site redness (01) 
Tablet Cefixime 01 00 Rashes and itching (01) 
Injection Ceftriaxone 04 00 Vomiting (03), Rashes (01) 
Tablet Amoxicillin 01 00 Maculopapular rash (01) 
Tablet Amoxicillin+Clavulanic acid 00 01 Loose stools (01) 
Tablet Levofloxacin 01 00 Rashes over injection site (01) 
Tablet Ofloxacin+Ornidazole 00 01 Rashes and itching (01) 
Tablet Isoniazid+Rifampicin+Pyrazinamide 00 06 Raised SGPT, SGOT (04), Rashes and itching (02) 
NSAIDs  
Tablet Ibuprofen 01 00 Bullous fixed drug eruptions (01) 
Vasopressors  
Injection Noradrenaline 01 00 Blackening of fingers and toes (01) 
Anticonvulsant  
Tablet Carbamazepine 01 00 Maculopapular rashes (01) 
Vitamins and minerals  
Injection B1B6B12 00 01 Rashes and itching (01) 
Injection Iron sucrose 01 00 Nausea and palpitations (01) 
Injection Ferric carboxy maltose 02 00 Hypersensitivity (02) 
Others  
Injection Potassium chloride 01 00 Injection site redness and itching (01) 
Injection Crystalline amino acid 01 00 Tachycardia (01) 
Injection Iohexol 01 00 Diarrhoea (01) 
Tablet Lithium 01 00 Cogwheel rigidity and hand tremors (01) 
Injection Pentavalent vaccine 00 01 Fever and rashes over injection site (01) 
Total 26 10 36 
Gor et al. 




Fig. 3: Organ sytem involved 
 
 
Fig. 4: WHO causality assessment 
 
DISCUSSION 
It is universally accepted that no drug is absolutely free from side 
effects. From previous studies it is observed that 5% of all hospital 
admissions were due to drug-induced problems and 10-20% of 
hospitalized patients develop ADRs [5, 6]. There is under-reporting of 
these ADRs due to lack of awareness and communication, which needs 
to be improved to prevent the iatrogenic diseases in a hospital setup. 
Female patients have a greater risk of ADRs compared to male patients 
as they use various groups of medications than their counter partner, 
predominantly of drugs for oral contraception, menopause, and 
pregnancy [7]. In some previous studies by lihite et al., patil et al., 
bhabor et al., james et al. most of the ADRs were reported in female 
patients [6, 8-10]. However, this study observed that the majority of 
ADRs were found in male, which is similar to findings by kharab et al. 
and sen et al. [12, 13]. In this study, most of the ADRs were reported 
from inpatient departments, which may be due to their presentation 
and spontaneous reporting by health care professionals during 
hospital stay. In this study, most of the ADRs were reported from 
pediatrics department, followed by skin department. This may be due 
to the reason that prescribers were more vigilant while prescribing to 
children and aware to report. Skin reactions are easily recognized and 
patients having this type of reaction are referred to skin department. 
In this study, most of the ADRs were reported from medications given 
by the parenteral route followed by medications given by the oral 
route, which is similar to another study by sen et al. [13]. Most of the 
ADRs were reported with an antimicrobial group of drugs in our study 
which is similar to studies by patil et al., bhabor et al., james et al., ingale 
et al., kharb et al. and patidar et al. [8-12, 14]. The organ system most 
commonly involved in this study was skin followed by the 
gastrointestinal system. The reason for the increased reporting of skin 
reactions could be due to the easy recognition of these reactions. A 
similar pattern was reported in studies by patil et al., james et al., ingale 
et al. and sen et al. [8, 10-11, 13]. Causality assessment using WHO UMC 
scale criteria [15] in this study showed that most of the reactions were of 
probable followed by possible. Similar findings were found in some 
other studies by patil et al., kharb et al. and sen et al. [8, 12-13]. A total of 
36 ADRs were reported in this study and most of ADRs 83.33% were 
reported by prescribers. So there is a need to increase awareness among 
health care staff regarding ADR reporting by conducting training 
sessions. Our hospital formulary is based on WHO essential list of 
medicines, which may be the reason for less reporting of ADRs, however 
some of the ADRs may have been missed. Impact of rational use of 
medications based on WHO essential medicine list and less reporting of 
ADRs need to be further explored in our setup. 
CONCLUSION 
Our study concluded that the most commonly reported ADRs were 
dermatological reactions like itching and rashes. Antimicrobials 
were the most common drug group involved in causing ADRs. Most 
of the responses in this study were probable according to WHO 
causality assessment scale. Even though there were continuous 
efforts for adverse drug event reporting awareness, there is still a 
need to sensitize health care professionals to improve reporting. 
This study has some limitations as it was an observational study 
carried over a short duration, and some of ADRs may not have been 
reported due to some reasons, however, still, it will give the 
information about current pattern of ADRs being reported by health 
care professionals at a tertiary care teaching hospital. 
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